Amdinocillin Pivoxil

CHEMBL1650818 Phase 4 Disetujui Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
439.6 g/mol
LogP
3.1
Phase
4

The orally active pivaloyloxymethyl ester prodrug of amdinocillin that is absorbed from the gut and converted to the active antibiotic form in the body. This prodrug formulation allows the otherwise poorly orally absorbed amdinocillin to be taken by mouth for treating urinary tract infections caused by gram-negative bacteria.

Berat Molekul

439,6000 g/mol

LogP

3,10

TPSA

114,00 Ų

Lipinski RO5

Lulus

Area Terapeutik

Mekanisme Kerja

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanisme

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Struktur 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2C(=O)[C@@H](/N=C/N3CCCCCC3)[C@H]2SC1(C)C

InChI

InChI=1S/C21H33N3O5S/c1-20(2,3)19(27)29-13-28-18(26)15-21(4,5)30-17-14(16(25)24(15)17)22-12-23-10-8-6-7-9-11-23/h12,14-15,17H,6-11,13H2,1-5H3/b22-12+/t14-,15+,17-/m1/s1

Molecular Formula

C21H33N3O5S

HBD / HBA

- / 7

Ikatan yang Dapat Dirotasi

8

Atom Berat

30

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

The orally active pivaloyloxymethyl ester prodrug of amdinocillin that is absorbed from the gut and converted to the active antibiotic form in the body. This prodrug formulation allows the otherwise poorly orally absorbed amdinocillin to be taken by mouth for treating urinary tract infections caused by gram-negative bacteria.

Administered as an inactive precursor that is metabolically converted to its active form in the body. This prodrug design improves bioavailability, absorption, or targeted delivery compared to the active compound.

Yes, Amdinocillin Pivoxil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1650818. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 115163. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.